Akari Therapeutics, Peak Bio Combined Entity Will Operate as Akari Therapeutics and Continue to Be Listed and Trade on Nasdaq Cap Market as AKTX >AKTX
Akari Therapeutics, Peak Bio Combined Entity Will Operate as Akari Therapeutics and Continue to Be Listed and Trade on Nasdaq Cap Market as AKTX >AKTX
Peak Bio合併後的實體Akari Therapeutics將以Akari Therapeutics的名義運營，並繼續以AKTX >AKTX的名義在納斯達克市值市場上市和交易
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊